Thrombosis Research
Volume 126, Issue 2 , Pages 81-87 , August 2010

Acquired and Congenital Risk Factors associated with Cerebral Venous Sinus Thrombosis

  • Robert D. McBane II

      Affiliations

    • Division of Cardiovascular Medicine, Department of Biochemistry and Molecular Biology, Mayo Clinic and Foundation for Education and Research, Rochester, MN 55905, United States
    • Section of Hematology Research, Department of Biochemistry and Molecular Biology, Mayo Clinic and Foundation for Education and Research, Rochester, MN 55905, United States
    • Corresponding Author InformationCorresponding author. Division of Cardiovascular Medicine, Mayo Clinic and Foundation for Education and Research, 200 S.W. First Street, Rochester, MN 55905, United States. Tel.: +1 507 266 3964; fax: +1 507 266 9302.
  • ,
  • Alfonso Tafur

      Affiliations

    • Division of Cardiovascular Medicine, Department of Biochemistry and Molecular Biology, Mayo Clinic and Foundation for Education and Research, Rochester, MN 55905, United States
  • ,
  • Waldemar E. Wysokinski

      Affiliations

    • Division of Cardiovascular Medicine, Department of Biochemistry and Molecular Biology, Mayo Clinic and Foundation for Education and Research, Rochester, MN 55905, United States
    • Section of Hematology Research, Department of Biochemistry and Molecular Biology, Mayo Clinic and Foundation for Education and Research, Rochester, MN 55905, United States

Received 19 December 2009 ,Revised 7 April 2010 ,Accepted 8 April 2010.

References 

  1. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med. 2005;352:1791–1798
  2. Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35:664–670
  3. Heit JA. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol. 2008;28:370–372
  4. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med. 2000;160:809–815
  5. Heit JA, Mohr DN, Silverstein MD, Petterson TM, O'Fallon WM, Melton LJ. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med. 2000;160:761–768
  6. Gosk-Bierska I, Wysokinski W, Brown RD, Karnicki K, Grill D, Wiste H, et al. Cerebral venous sinus thrombosis: Incidence of venous thrombosis recurrence and survival. Neurology. 2006;67:814–819
  7. Wysokinska EM, Wysokinski WE, Brown RD, Karnicki K, Gosk-Beirska I, Grill D, et al. Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis. Neurology. 2008 Feb 19;70(8):627–633
  8. Wysokinski WE, Gosk-Bierska I, Greene EL, Grill D, Wiste H, McBane RD. Clinical characteristics and long-term follow-up of patients with renal vein thrombosis. Am J Kidney Dis. 2008;51:224–232
  9. Wysokinska EM, Hodge D, McBane RD. Ovarian vein thrombosis: incidence of recurrent venous thromboembolism and survival. Thromb Haemost. 2006;96:126–131
  10. Thatipelli MR, McBane RD, Hodge DO, Wysokinski WE. Survival and recurrence in patients with splanchnic vein thromboses. Clin Gastroenterol Hepatol. 2010;8:200–205
  11. Bombeli T, Basic A, Fehr J. Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems. Am J Hematol. 2002;70:126–132
  12. Coutinho JM, Ferro JM, Canhão P, Barinagarrementeria F, Cantú C, Bousser MG, et al. Cerebral venous and sinus thrombosis in women. Stroke. 2009;40:2356–2361
  13. Heit JA, O'Fallon WM, Petterson TM, Lohse CM, Silverstein MD, Mohr DN, et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med. 2002;162:1245–1248
  14. Ferrera PC, Pauze DR, Chan L. Sagittal sinus thrombosis after closed head injury. Am J Emerg Med. 1998;16:382–385
  15. Ingunza I, Hacker H. Cerebral venous and sinus thrombosis in neurosurgical patients. Radiologe. 1972;12:48–52
  16. Younis RT, Lazar RH, Anand VK. Intracranial complications of sinusitis: a 15-year review of 39 cases. Ear Nose Throat J. 2002;81:636–638
  17. Haisa T, Yoshida S, Ohkubo T, Yoshikawa K, Machida T. Primary empty sella in association with superior sagittal sinus thrombosis and dural arteriovenous malformation. Case report. J Neurosurg. 1994;81:122–125
  18. Larkey D, Williams CR, Fanning J, Hilgers RD, Graham DR, Fortin CJ. Fatal superior sagittal sinus thrombosis associated with internal jugular vein catheterization. Am J Obstet Gynecol. 1993;169:1612–1614
  19. Wester K, Mork S, Smievoll AI. Neuroblastoma and venous sinus thrombosis in an adult patient. Br J Neurosurg. 1997;11:241–244
  20. deVeber G, Andrew M, Adams C, Bjornson B, Booth F, Buckley DJ, et al. Cerebral sinovenous thrombosis in children. N Engl J Med. 2001;345:417–423
  21. Ferro JM, Canhão P, Bousser MG, Stam J. Barinagarrementeria F; ISCVT Investigators. Cerebral vein and dural sinus thrombosis in elderly patients. Stroke. 2005;36:1927–1932
  22. Martinelli I, Battaglioli T, Pedotti P, Cattaneo M, Mannucci PM. Hyperhomocysteinemia in cerebral vein thrombosis. Blood. 2003;102:1363–1366
  23. de Bruijn SF, Stam J, Koopman MM, Vandenbroucke JP. Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users and in carriers of hereditary prothrombotic conditions. The Cerebral Venous Sinus Thrombosis Study Group. BMJ. 1998;316:589–592
  24. Dentali F, Crowther M, Ageno W. Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis. Blood. 2006;107:2766–2773
  25. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. Lancet. 1995;346:1575–1582
  26. Kitty W, Bloemenkamp M, Rosendaal FR, Helmerhorst FM, Vandenbroucke JP. Higher Risk of Venous Thrombosis During Early Use of Oral Contraceptives in Women With Inherited Clotting Defects. Arch Intern Med. 2000;160:49–52
  27. Koenen RR, Christella M, Thomassen LG, Tans G, Rosing J, Hackeng TM. Effect of oral contraceptives on the anticoagulant activity of protein S in plasma. Thromb Haemost. 2005;93:853–859
  28. Kluft C, Lansink M. Effect of oral contraceptives on haemostasis variables. Thromb Haemost. 1997;78:315–326
  29. Legnani C, Cosmi B, Valdre L, Boggian O, Bernardi F, Coccheri S, et al. Venous thromboembolism, oral contraceptives and high prothrombin levels. J Thromb Haemost. 2003;1:112–117
  30. Tchaikovski SN, Rosing J. Mechanisms of Estrogen-Induced Venous Thromboembolism. Thromb Res. 2010;Electronic publication ahead of print
  31. Meijers JC, Middeldorp S, Tekelenburg W, et al. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives. Thromb Haemost. 2000;84:9–14
  32. Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med. 1998;338:1793–1797
  33. Christopher R, Nagaraja D, Dixit NS, Narayanan CP. Anticardiolipin antibodies: a study in cerebral venous thrombosis. Acta Neurol Scand. 1999;99:121–124
  34. Zubkov AY, McBane RD, Brown RD, Rabinstein AA. Brain lesions in cerebral venous sinus thrombosis. Stroke. 2009;40:1509–1511
  35. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated Protein C. Nature. 1994;369:64–67
  36. Falcon CR, Cattaneo M, Panzeri D, Martinelli I, Mannucci PM. High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis. Arterioscler Thromb. 1994;14:1080–1083
  37. den Heijer M, Blom HJ, Gerrits WB, Rosendaal FR, Haak HL, Wijermans PW, et al. Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?. Lancet. 1995;345:882–885
  38. den Heijer M, Koster T, Blom HJ, Bos GM, Briet E, Reitsma PH, et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med. 1996;334:759–762
  39. Keijzer MB, den Heijer M, Blom HJ, Bos GM, Willems HP, Gerrits WB, et al. Interaction between hyperhomocysteinemia, mutated methylenetetrahydrofolatereductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosis. Thromb Haemost. 2002;88:723–728
  40. McBane RD, Miller RS, Hassinger NL, Chesebro JH, Nemerson Y, Owen WG. Tissue prothrombin. Universal distribution in smooth muscle. Arterioscler Thromb Vasc Biol. 1997;17:2430–2436
  41. Dihanich M, Kaser M, Reinhard E, Cunningham D, Monard D. Prothrombin mRNA is expressed by cells of the nervous system. Neuron. 1991;6:575–581
  42. Weinstein JR, Gold SJ, Cunningham D, Gall CM. Cellular localization of thrombin receptor mRNA in rat brain: expression by mesencephalic dopaminergic neurons and codistribution with prothrombin mRNA. J Neurosci. 1995;15:2906–2919
  43. Tsai LK, Jeng JS, Liu HM, Wang HJ, Yip PK. Intracranial dural arteriovenous fistulas with or without cerebral sinus thrombosis: analysis of 69 patients. J Neurol Neurosurg Psychiatry. 2004;75:1639–1641
  44. Gerlach R, Yahya H, Rohde S, Bohm M, Berkefeld J, Scharrer I, et al. Increased incidence of thrombophilic abnormalities in patients with cranial dural arteriovenous fistulae. Neurol Res. 2003;25:745–748
  45. Kearon Clive, Kahn Susan R, Agnelli Giancarlo, Goldhaber Samuel, Raskob Gary E, Anthony J. Comerota Antithrombotic Therapy for Venous Thromboembolic Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:454S–545S
  46. Kernohan JW, Woltman HW. Incisura of the crus due to contralateral brain tumor. Proc Staff Meet Mayo Clinic. 1928;3:69–70

PII: S0049-3848(10)00253-7

doi: 10.1016/j.thromres.2010.04.015

Thrombosis Research
Volume 126, Issue 2 , Pages 81-87 , August 2010